Coya Therapeutics (COYA) Retained Earnings (2021 - 2026)

Coya Therapeutics (COYA) has 6 years of Retained Earnings data on file, last reported at $118.1 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 345.9% year-over-year to $118.1 million; the trailing twelve-month figure through Mar 2026 stood at $118.1 million (up 345.9% YoY), and the FY2025 full-year result was $105.0 million, up 30.73% from the prior year.
• Retained Earnings improved to $118.1 million in Q1 2026, from $105.0 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $118.1 million in Q1 2026 to a low of -$56.3 million in Q3 2025.
• A 5-year average of $6.1 million and a median of -$22.2 million in 2023 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings slumped 217.73% in 2022 and surged 410.61% in 2024, its largest moves.
• Tracing COYA's Retained Earnings over 5 years: stood at -$17.9 million in 2022, then sank by 44.7% to -$25.9 million in 2023, then surged by 410.61% to $80.3 million in 2024, then surged by 30.73% to $105.0 million in 2025, then climbed by 12.52% to $118.1 million in 2026.
• Business Quant data shows COYA's Retained Earnings at $118.1 million in Q1 2026, $105.0 million in Q4 2025, and -$56.3 million in Q3 2025.